Circulation: Arrhythmia and Electrophysiology

DECEMBER 21, 2023

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Inflammation may promote atrial fibrillation (AF) recurrence after catheter ablation. mg twice daily or placebo for 10 days. mg twice daily or placebo for 10 days. The first dose of the study drug was administered within 4 hours before ablation.

Atrial Fibrillation 40

Atrial Fibrillation Ablation Chest Pain Atrial Flutter 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

Abstract Introduction The use of flecainide and propafenone for medical cardioversion of atrial fibrillation (AF) and atrial flutter/intra-atrial reentrant tachycardia (IART) is well-described in adults without congenital heart disease (CHD).

Congenital Heart Disease 40

Congenital Heart Disease Atrial Fibrillation Congenital Heart Disease 40

Journal of Cardiovascular Electrophysiology

DECEMBER 7, 2023

FAAM ablation successfully decreased the recurrence rate of atrial tachyarrhythmia compared with conventional non-PV foci ablation. Abstract Introduction Treatment of recurrent atrial fibrillation (AF) is sometimes challenging due to non-pulmonary vein (PV) foci. The RHYTHMIA system was used to perform all the procedures.

Ablation 40

Ablation Atrial Fibrillation Atrial Flutter Tachycardia 40

Journal of Cardiovascular Electrophysiology

OCTOBER 19, 2023

Although the QDOT MICRO™ Catheter was mainly designed for pulmonary vein isolation (PVI) its versatility to treat atrial fibrillation (AF) and other types of arrhythmias was recently evaluated by the FAST and FURIOUS study series and other studies and will be presented in this article.

Arrhythmia 40

Arrhythmia Ablation Atrial Flutter Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

DECEMBER 17, 2024

Abstract Background Dofetilide is a class III antiarrhythmic agent approved for the treatment of atrial fibrillation and atrial flutter. Given the efficacy of other class III agents, it has been used off-label for the treatment of premature ventricular complexes (PVCs) and ventricular tachycardias (VTs).

Tachycardia 40

Tachycardia Heart Disease Atrial Flutter Heart Transplant 40

Dr. Smith's ECG Blog

DECEMBER 20, 2024

Cardioversion is most beneficial for reentrant arrhythmias ( e.g. VT, atrial flutter, AVNRT, atrial fibrillation) because it terminates the reentry circuit. Atrial tachycardia can occasionally be due to reentry, but reentrant circuits usually have a more stable cycle length without so much beat to beat variability.

Chest Pain 75

Chest Pain Tachycardia Pacemaker Defibrillator 75

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

ABSTRACT Introduction The safety and efficacy of paroxysmal atrial fibrillation (PAF) ablation with the HELIOSTAR multielectrode radiofrequency (RF) balloon catheter have been demonstrated in European studies; data from elsewhere are lacking. Central Illustration. Image is courtesy of Biosense Webster, Inc., All rights reserved.

Atrial Fibrillation 40

Atrial Fibrillation Quality of Life Atrial Flutter Ablation 40

DAIC

MARCH 5, 2024

a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). Atrial Fibrillation. Circulation.

Ablation 59

Ablation Atrial Fibrillation Atrial Flutter Pulmonary 59

Dr. Smith's ECG Blog

MARCH 6, 2020

There is atrial activity before every QRS, but that activity has negative polarity, so it is not sinus rhythm. There are clearly no flutter waves, so it is not atrial flutter (a "macro-reentrant" atrial tachycardia) Is it AVNRT originating at the superior pole of the AV node, resulting in a retrograde P-wave before the QRS?

Heart Failure 52

Heart Failure Tachycardia Atrial Flutter Cardiomyopathy 52

Dr. Smith's ECG Blog

APRIL 8, 2015

Electrophysiologic studies were performed in selected patients only as clinically appropriate. Arrhythmias as a cause of syncope were diagnosed by cardiac monitoring or electrophysiologic testing. Holter monitoring, or intracardiac electrophysiologic studies, alone or in combination (diagnostic yields, 5% to 35%).

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52

DAIC

OCTOBER 30, 2024

The Affera system was designed to address procedural challenges faced by the electrophysiology community while maintaining a high standard of safety and efficacy for patients. tim.hodson Wed, 10/30/2024 - 13:42 Oct. With this approval, Medtronic now offers two PFA technologies available for patients with Afib.

Ablation 52

Ablation AFIB Atrial Fibrillation Atrial Flutter 52